Key Events This Week
31 Aug: Stock opens strong at Rs.80.37 (+2.07%) despite Sensex decline
1 Sep: Downgrade to Hold announced; stock drops 3.09% to Rs.77.89
2 Sep: Valuation metrics shift to very attractive; slight recovery to Rs.78.37 (+0.62%)
3 Sep: Moderate gain to Rs.79.44 (+1.37%) on renewed buying interest
4 Sep: Profit-taking leads to 3.20% drop, closing at Rs.76.90

Astal Laboratories Ltd is Rated Hold
2026-09-13 10:10:18Astal Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Astal Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-09-03 08:00:11Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive grade. Despite recent market headwinds and a downgrade in its Mojo Grade from Buy to Hold, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a compelling entry point for investors seeking value in a challenging environment.
Read full news article
Astal Laboratories Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals
2026-09-02 08:10:09Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating downgraded from Buy to Hold as of 1 September 2026. This revision reflects a nuanced assessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals. While the company continues to demonstrate robust financial growth, recent technical indicators and valuation metrics have prompted a more cautious stance among investors.
Read full news article
Astal Laboratories Ltd is Rated Buy
2026-09-01 10:10:57Astal Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 20 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 September 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Astal Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-08-25 08:00:11Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has seen its valuation parameters shift from very attractive to attractive, reflecting a nuanced change in market perception. With a current price of ₹83.67 and a recent day gain of 2.41%, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more balanced valuation compared to its historical and peer averages, prompting investors to reassess its price attractiveness amid steady operational metrics.
Read full news article
Astal Laboratories Ltd Downgraded to Buy Amid Mixed Technicals and Improving Financials
2026-08-21 08:05:05Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating downgraded from Strong Buy to Buy as of 20 Aug 2026. This adjustment reflects a nuanced shift across four key parameters: quality, valuation, financial trend, and technical indicators. While the company posted robust quarterly financials in June 2026, certain valuation and technical signals have moderated the overall outlook, prompting a recalibration of its mojo grade to 74.0.
Read full news articleAnnouncement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015
11-Sep-2026 | Source : BSESubmission of Intimation under SEBI (PIT) Regulations 2015.
Announcement under Regulation 30 (LODR)-Newspaper Publication
09-Sep-2026 | Source : BSESubmission of newspaper publication of AGM Notice.
Announcement Under Regulation 30 (LODR) - Letter Of Annual Report & AGM Notice Web Link.
07-Sep-2026 | Source : BSEAttached.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available







